<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d1 20130915//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d1">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Biomedical Research and Therapy</journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2198-4093</issn>
      <publisher>
        <publisher-name>BioMedPress</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.7603/s40730-016-0012-x</article-id>
      <article-categories>
        <subj-group subj-group-type="display-channel">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Biomedical Research and Therapy</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A mouse model of osteonecrotic femoral head induced by methylprednisolone and liposaccharide</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Thi -Ngan Le#</surname>
            <given-names>Ha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thi Phi#</surname>
            <given-names>Lan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thi-Thanh Dao</surname>
            <given-names>Thuy</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim Phan</surname>
            <given-names>Ngoc</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Van Pham</surname>
            <given-names>Phuc</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Bich Vu</surname>
            <given-names>Ngoc</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <aff id="aff1">
          <institution>Laboratory of Research and Application Stem Cell, University of Sciences, Vietnam National University, Ho Chi Minh City, Vietnam</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>For correspondence: <email>vbngoc@hcmus.edu.vn</email></corresp>
        <fn fn-type="con" id="equal-contrib">
          <label>*</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>25</day>
        <month>03</month>
        <year>2016</year>
      </pub-date>
      <volume>3</volume>
      <issue>3</issue>
      <fpage>548</fpage>
      <lpage>556</lpage>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>01</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>03</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#169; The Author(s) 2016</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/CC-BY/4.0">
          <license-p>This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Introduction</p>
        <p>Osteonecrosis of the femoral head is caused by various factors, including prolonged use of steroid drugs, use of alcohol, vascular injuries and hemoglobinopathies. This study aims to develop a mouse model for glucocorticoid-induced avascular necrosis (AVN) of the femoral head.</p>
        <p>Methods</p>
        <p>Adult mice were randomly divided into two groups: experimental and control. Group A (the experimental group) was given (via intramuscular injection) 10 mg/kg of lipopolysaccharide (LPS) and 30 mg/kg of methylprednisolone (MPS). Each mouse additionally received MPS in divided oral doses of 13 mg/kg for 10 consecutive days. Group B (the control group) received normal saline at the same location and same volume as those in Group A. Histological changes of the femoral heads were observed by electron microscopy at 3, 5, and 7 weeks after the last chemical injection. The percentage of empty lacunae was measured randomly and the expression of fibrocartilage was evaluated using an image analyzing system. The expression of CD31 and VEGF-R2 were observed by immunohistochemistry. The bone marrow-derived mononuclear cells were stained with propidium iodide and cell cycle was analyzed by flow cytometry.</p>
        <p>Results</p>
        <p>The results showed that at weeks 3 and 5, mice in Group A showed an increase in body weight. From weeks 5 to 7, mouse body weight in both groups remained constant. No difference in bone morphology was observed at week 7. The percentage of empty lacunae was 5.87 &#177; 2.49% at week 5 and 21.58 &#177; 8.10% at week 7. After 7 weeks, chondrocyte degeneration and fibrocartilage expression were observed. Moreover, the density of CD31 and VEGF-R2 markers increased in the femoral head. The rate of apoptosis in the bone marrow increased at week 3 then decreased.</p>
        <p>Conclusion</p>
        <p>The data show that MPS, combined with LPS, can induce in mice features typical of early AVN of the femoral head.</p>
      </abstract>
      <kwd-group>
        <kwd>Avascular necrosis of femoral head</kwd>
        <kwd>osteonecrosis</kwd>
        <kwd>mouse model</kwd>
        <kwd>methylprednisolone</kwd>
        <kwd>lipopolysaccha-ride</kwd>
        <kwd>glucocorticoid</kwd>
        <kwd>steroids</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1" sec-type="intro">
      <title>Introduction</title>
      <p>AVN (also called osteonecrosis) of the femoral head is defined as a pathological state with death and/or necrosis of bone marrow cells and osteocytes due to interruption of blood supply to the bone <xref ref-type="bibr" rid="ref12">Kerachian et al., 2010a</xref>. This leads to the collapse of the necrotic segment. Factors that may cause AVN include steroid administration, alcohol abuse, hemoglobinopathies, traumatic events, vascular injury and idiopathic origins <xref ref-type="bibr" rid="ref11">J. Anthony Parker, 1988</xref>. In the early stage, patients do not show distinct symptoms but structural and cellular changes can be observed at the histological level. To date, treatment for this disease includes non-weight bearing therapy, bone grafting (for physical support) and tantalum implants <xref ref-type="bibr" rid="ref46">Zalavras et al., 2003b</xref>.</p>
      <p>Glucocorticoids are absorbed through the cell membrane by special receptors and affect lipid, protein and carbohydrate metabolism. The effect of glucocorticoids on bone can be summarized by three major mechanisms: (i) the imbalance between bone resorption and bone remodeling, (ii) vascular occlusion or vascular injury, and (iii) activation of apoptotic signaling pathway by some glucocorticoids <xref ref-type="bibr" rid="ref46">Zalavras et al.,2003b</xref>. At the cellular level, glucocorticoids can decrease mitosis, increase apoptosis by Fas pathway and inhibit type II collagen synthetic ability in osteoblasts. For osteoclasts, glucocorticoids increase the expression of differentiation cytokines, e.g. G-CSF, RANK-L and IL-6. Similar to their effect on osteoblasts, glucocorticoids can stimulate apoptosis of osteocytes and change their elastic modulus. In addition, high levels of glucocorticoids can cause inhibition of lymphoid enhancer-binding factor 1/transcription factor 7 (LEF/TCF), associated with beta-catenin, in canonical Wnt signaling pathway <xref ref-type="bibr" rid="ref19">MacDonald et al., 2009</xref>; therefore, the transition from G1 to S phase can be restricted (Ichiseki et al.). Moreover, glucocorticoids can cause reduced growth of cartilage and reduced synthesis of collagen and proteoglycans. Many animal models of AVN have been established using different glucocorticoids, such as prednisolone <xref ref-type="bibr" rid="ref27">Qian et al.,2008</xref>, methylprednisolone (MPS) <xref ref-type="bibr" rid="ref9">Ichiseki et al., 2004b</xref>, and dexamethasone <xref ref-type="bibr" rid="ref44">Yin et al., 2006</xref>. Among them, MPS, a synthetic glucocorticoid, has been demonstrated to effectively increase osteonecrosis <xref ref-type="bibr" rid="ref24">Miyanishi et al., 2005</xref>.</p>
      <p>Lipopolysaccharides (LPS), molecules found in the outer membrane of gram-negative bacteria, have immunostimulatory properties; they can induce systemic inflammation and sepsis through Toll-like Receptor 4 <xref ref-type="bibr" rid="ref2">Beutler and Rietschel, 2003</xref>. Therefore, application of LPS in our model should affect cartilage <xref ref-type="bibr" rid="ref3">Bobacz et al., 2007</xref><xref ref-type="bibr" rid="ref8">Ichiseki et al., 2004a</xref>. Several studies have demonstrated that LPS activates many transcription factors and cytokines, including NF-&#954;B, IL-33 <xref ref-type="bibr" rid="ref6">Espinassous et al., 2009</xref>. In fact, the bone marrow and immune system are functionally interconnected <xref ref-type="bibr" rid="ref47">Zupan et al., 2013</xref>. Thus, cellular immune and pro-inflammatory cytokines can impact bone cells. Recent studies have reported that LPS can enhance a glucocorticoidinduced disease progression model <xref ref-type="bibr" rid="ref28">Qin et al., 2006</xref><xref ref-type="bibr" rid="ref30">Ryoo et al., 2014</xref><xref ref-type="bibr" rid="ref43">Wu et al., 2008</xref>.</p>
      <p>In this study, AVN of the femoral head was induced by combining LPS and MPS in an effort to develop an experimental mouse model. Development of such a model will be useful for evaluation of effective therapeutic modalities for AVN.</p>
    </sec>
    <sec id="s2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec id="s2-1">
        <title>Establishment of a Mouse Model of AVN</title>
        <p>Adult mice (ranging from 4-8 weeks in age and 25 &#8211; 30 grams in weight) were randomly divided into two groups. Group A (experimental group) received intravenous injection of 10 mg/kg LPS and 30 mg/kg MPS (<xref ref-type="fig" rid="tab1"> Table 1 </xref>). Moreover, each mouse received an additional administration of Medrol (Pfizer, Italy), given orally in divided doses of 13 mg/kg for 10 days. Group B (control group) received normal saline; the injection location and volume were the same as those used for Group A. The animals were evaluated at weeks 3, 5 and 7, after the last injection.</p>
        <fig id="tab1">
          <label>Table 1</label>
          <caption>
            <p>Drug injection diagnosis for experimental group</p>
          </caption>
          <graphic xlink:href="s40730-016-0012-x/tab1.png"/>
        </fig>
      </sec>
      <sec id="s2-2">
        <title>Histological Assay</title>
        <p>Femurs were collected from sacrificed mice and fixed in paraformaldehyde (4%) for 2-3 days. To demineralize the calcium, femurs were transferred to phosphate buffered saline containing 10% disodium ethylene diamine triacetic acid (PBS-EDTA) for 10-14 days or until the femurs were tender. The femurs were then dehydrated by glucose (10%) and later embedded in tissue freezing medium and cut into 10-15 &#956;m-thick sections. Finally, samples were stained with hematoxylin and eosin dye and observed by microscopy. For each section, several random fields were observed and evaluated for number of bone lacunae. The proportion of empty lacunae to bone lacunae was calculated.</p>
        <p>To evaluate the expression of proteoglycans, the samples were stained with Safranin O. Images were analyzed by imageJ software (National Institutes of Health, USA).</p>
      </sec>
      <sec id="s2-3">
        <title>Immunohistochemistry</title>
        <p>For detection of VEGF and CD31 expression (in the femoral head following drug treatment) immunohistochemistry was used. Tissues were sectioned according to the histological assay mentioned above, and stained with Rat-anti mouse VEGF-R2 (Flk1) FITC (BD Bioscience, US) and Rat-anti mouse CD31 FITC (BD Bioscience, US). Hoechst dye was used for nuclear staining. The results were observed by fluorescent microscopy.</p>
      </sec>
      <sec id="s2-4">
        <title>Cell cycle assay</title>
        <p>Bone marrow-derived mononuclear cells were collected by incubation in hemolysis solution. Mononuclear cells were fixed in ethanol (70%) for 24 hours and stained with propidium iodide for 10 minutes. Cell cycle analysis was done by flow cytometry.</p>
      </sec>
      <sec id="s2-5">
        <title>Statistical Analysis</title>
        <p>The data were analyzed by GraphPad Prism 6.0 software and Microsoft Office 2011. Images were analyzed by ImageJ software.</p>
      </sec>
    </sec>
    <sec id="s3" sec-type="results">
      <title>Results</title>
      <sec id="s3-1">
        <title>Weight change</title>
        <p>Weight of mice in both groups increased over time. However, the rate of weight gain was faster in the experimental group. The rate of weight gain was approximately 19.63% &#177; 8.29% at week 3 and 30.01% &#177; 13.55% at week 5, compared to the control group (14.42% &#177; 5.69%). From weeks 5 to 7, the body weight of mice in both groups remained constant.</p>
      </sec>
      <sec id="s3-2">
        <title>Morphological changes of the cartilage and bone</title>
        <p>To observe the occurrence of AVN of the femoral head, we used microscopy and several cytological and histological examinations. After 7 weeks of drug administration, bone morphology showed no significant change in treated mice compared to control mice, by observation with the naked eye and by stereoscopic microscopy (<xref ref-type="fig" rid="fig1"> Figure 1A </xref>). However, the femoral head of drug-treated mice changed to an opaque color, whereas the femoral head in control mice remained white in color (<xref ref-type="fig" rid="fig1"> Figure 1B </xref>). Moreover, there were dents present on the femoral head of drug-induced mice (<xref ref-type="fig" rid="fig1"> Figure 1C </xref>).</p>
        <fig id="fig1">
          <label>Figure 1</label>
          <caption>
            <title>Morphological changes of the cartilage and bone</title>
            <p>The morphology of the femur (A), and femoral head of the control group (B) and drug-induced group (C), after 7 weeks. Samples were observed under stereoscopic microscopy.</p>
          </caption>
          <graphic xlink:href="s40730-016-0012-x/fig1.png"/>
        </fig>
      </sec>
      <sec id="s3-3">
        <title>Bone lacunae</title>
        <p>The loss of osteocytes in bone tissue is one evident change which indicates AVN of the femoral head <xref ref-type="bibr" rid="ref8">Ichiseki et al., 2004a</xref>. Our study showed that the percentage of empty lacunae gradually increased from week 3 to week 7. While the empty bone lacunae in the control group at week 3 was 0.28% &#177; 0.28% (<xref ref-type="fig" rid="fig2"> Figure 2A </xref>), the ratio in the drug-treated group was 0.68% &#177; 0.16%, and reached 5.87% &#177; 2.49% in week 5 and 21.58% &#177; 8.10% in week 7 (<xref ref-type="fig" rid="fig2"> Figure 2B </xref>) (p&lt;0.05). The rate of bone defect at week 3 was not different compared to control mice ((p&gt;0.05), but there was a statistically significant difference in the groups at week 5 and also at week 7 (p&lt;0.05).</p>
        <fig id="fig2">
          <label>Figure 2</label>
          <caption>
            <title>Analysis of bone defect following drug induction</title>
            <p>Hematoxylin&#8211;eosin staining from a control mouse (A) versus a drug-treated mouse (B), at week 7. Lacuna in the bone cells could clearly be observed, indicated by arrows (original magnification X200). The percentage of bone lacunea increased over time (C). Each column shows mean &#177; SD of data from three independent experiments (*: p&lt;0.05).</p>
          </caption>
          <graphic xlink:href="s40730-016-0012-x/fig2.png"/>
        </fig>
      </sec>
      <sec id="s3-4">
        <title>Histological Assay</title>
        <p>The histological features of chondrocytes at the femur head looked distinctly different in the control group versus drug-treated group, at week 7. In the control tissue, the normal cartilage cells were inlaid in the chamber with tight contact structures (blue arrow) (<xref ref-type="fig" rid="fig3"> Figure 3A </xref>). In the drug-treated tissue, there were visible hollow cavities between the chondrocytes, indicative of loss of tissue structure, and the cartilage cells looked injured and atrophic (blue arrow) (<xref ref-type="fig" rid="fig3"> Figure 3B </xref>).</p>
        <fig id="fig3">
          <label>Figure 3</label>
          <caption>
            <title>Hematoxylin and eosin (H&amp;E)-stained sections representative of cartilage</title>
            <p>(A) Control tissue, blue arrows for normal chondrocytes; (B) Induced tissue, blue arrows for injured chondrocytes (B).</p>
          </caption>
          <graphic xlink:href="s40730-016-0012-x/fig3.png"/>
        </fig>
      </sec>
      <sec id="s3-5">
        <title>The distribution of proteoglycan</title>
        <p>Cartilage samples were stained by safranin O dye (<xref ref-type="fig" rid="fig4"> Figure 4A </xref> , <xref ref-type="fig" rid="fig4"> Figure 4B </xref> ). The proteoglycan content in normal cartilage was stained orange to red, fibrocartilage was stained green, and nuclei were stained black. Proteoglycan expression was recorded by analyzing the digital photomicrographs via ImageJ software. Statistical results showed the proteoglycan expression level in the normal (control) group to be at 2.63 &#177; 0.47 while only at 0.98 &#177; 0.18 in the drug-induced group, after 7 weeks. This indicated a statistically significant reduction in the amount of proteoglycan expression in mice, after treatment with LPS and MPS (p&lt;0.001) (<xref ref-type="fig" rid="fig4"> Figure 4C </xref>).</p>
        <fig id="fig4">
          <label>Figure 4</label>
          <caption>
            <title>Expression of proteoglycans in chondrocytes at the femur head</title>
            <p>Safranin O&#8211;stained section representative of control mouse (A) and drug-treated mouse (B). Red region represents proteoglycan expression, green region represents fibrocartilage expression, and black staining represents nuclei. Proteoglycan expression was recorded by analysis with ImageJ software (C). ****p&lt;0.001.</p>
          </caption>
          <graphic xlink:href="s40730-016-0012-x/fig4.png"/>
        </fig>
      </sec>
      <sec id="s3-6">
        <title>Cell cycle assay</title>
        <p>There was a slight decrease in the G0/G1-phase of the cell cycle in the treatment group at week 3 (84.11% &#177; 4.86%), compared to the control group (85.36% &#177; 2.78%). These changes continued post week 3 (81.23% &#177; 6.47%) through week 7 (81.89% &#177; 5.30%). However, statistical analysis showed no significant difference observed in the G0-G1 phase of cell cycle arrest during the drug induction process (<xref ref-type="fig" rid="fig5"> Figure 5A </xref>,<xref ref-type="fig" rid="fig5"> Figure 5D </xref> ).</p>
        <fig id="fig5">
          <label>Figure 5</label>
          <caption>
            <title>Effects of methylprednisolone and lipopolysaccharide on apoptosis and cell cycle of bone marrow-derived mononuclear cells</title>
            <p>The percentage of G0 and G1 phase cells at 3, 5 and 7 weeks in the drug-induced group do not show significant differences (P&gt;0.05), compared to the control group (A). The percentage of apoptotic cells in the drug-treated group at week 3 was significant higher (*P&lt;0.05) than for week 5 and week 7 (C). Proliferative phases of the cell cycle at week 5 and week 7 were higher than week 3 (B). Flow cytometry was performed to detect cell cycle. Cells of control mice did not show an apoptosis phase (D), unlike cells of drug-induced mice, at week 3 (E).</p>
          </caption>
          <graphic xlink:href="s40730-016-0012-x/fig5.png"/>
        </fig>
        <p>The main changes were found in the proliferative phase (S-G2/M phase) and apoptotic phase. The percentage of cell cycle arrest at G0/G1 phase increased significantly (p&lt;0.05) in the 5-week and 7-week drug-induced group (17.69% &#177; 3.59% and 17.62% &#177; 4.11%, respectively), compared to the 3-week drug-induced group (11.78% &#177; 2.88%) and control group (13.66% &#177; 3.56%) (<xref ref-type="fig" rid="fig5"> Figure 5B </xref>).</p>
        <p>The mononuclear cells in drug-induced bone marrow showed an increased level of apoptosis (p&lt;0.05) at week 3 (4.11% &#177; 4.60%), compared to cells in control mice at the same time point (0.97% &#177; 0.53%). After 3 weeks, the level of apoptosis gradually reduced (<xref ref-type="fig" rid="fig5"> Figure 5C </xref>, <xref ref-type="fig" rid="fig5"> Figure 5E </xref> ).</p>
      </sec>
      <sec id="s3-7">
        <title>Immunohistochemistry</title>
        <p>Expression of vascular endothelial growth factor receptor 2 (VEGF-R2) and CD31 in chondrocytes were also evaluated by immunohistochemistry; nuclei were indicated by Hoechst staining. VEGF-R2 and CD31 protein levels were assessed to determine damage to cartilage and vascular structures. Immunohistochemistry analysis showed that VEGFR-2 and CD31 signals were scattered in cartilage tissue. The expression of CD31 in the normal mouse (control group) was lower than in the drug-induced group at week 7 (<xref ref-type="fig" rid="fig6"> Figure 6 </xref>). VEGFR-2 protein expression is different in control mice compared to drug-induced mice (<xref ref-type="fig" rid="fig7"> Figure 7 </xref>).</p>
        <fig id="fig6">
          <label>Figure 6</label>
          <caption>
            <title>Effects of MPS and LPS on CD31 expression</title>
            <p>In control mouse chondrocytes (A, B,C) and drug-induced mouse chondrocytes (D, E,F); Nuclei stained with Hoechst are blue (A, D); CD31 positive cells stained with fluorescein are green (B, E); merge of the two (C, F). (original magnification X200).</p>
          </caption>
          <graphic xlink:href="s40730-016-0012-x/fig6.png"/>
        </fig>
        <fig id="fig7">
          <label>Figure 7</label>
          <caption>
            <title>Effects of MPS and LPS on VEGF-R2 expression</title>
            <p>n control mouse chondrocytes (A, B,C) and drug-induced mouse chondrocytes (D, E,F); Nuclei stained with Hoechst are blue (A, D); VEGF-R2 positive cells stained with fluorescein are red (B, E); merge of the two (C, F) (original magnification X200).</p>
          </caption>
          <graphic xlink:href="s40730-016-0012-x/fig7.png"/>
        </fig>
      </sec>
    </sec>
    <sec id="s4" sec-type="discussion">
      <title>Discussion</title>
      <p>A decrease in chondrocyte numbers may be the result of injury, induced by mechanical damage or steroid drug use <xref ref-type="bibr" rid="ref4">Chen et al., 2001</xref>. Cartilage injury leads to apoptosis or necrosis and can contribute to changes in tissue structure. MPS and LPS have been demonstrated to induce change in cartilage structure. Many glycosaminoglycans attach to proteoglycans <xref ref-type="bibr" rid="ref5">Esko JD et al., 2009</xref>, which are secreted into the cartilage matrix by chondrocytes. The interaction between chondrocytes and cartilage matrix play an important role in proliferation and cartilage remodeling.</p>
      <p>MPS causes a reduction in size of aggrecans or aggregate proteoglycan in the cartilage matrix. This leads to the loss of glycosaminoglycans <xref ref-type="bibr" rid="ref36">Todhunter et al., 1996</xref>. LPS activates TLR-4, a receptor for LPS which has been identified in chondrocytes. Upon LPS-induced TLR-4 activation, enhanced phosphorylation of p38 MAPK can occur; some studies have shown that activation of p38 MAPK leads to decrease of GAG synthesis in chondrocytes in vitro. In addition, enhanced regulation of IL-1&#946;, controlled by p38 MAPK, inhibits the production of cartilage matrix <xref ref-type="bibr" rid="ref1">Azuma et al., 2000</xref>and consequently to the loss of matrix structure.</p>
      <p>Moreover, Nakazawa et al. showed that apoptosis increases in corticosteroid-induced chondrocytes <xref ref-type="bibr" rid="ref25">Nakazawa et al., 2002</xref>. The membrane of chondrocytes partly expresses Fas antigen therefore stimulation of Fas receptor can induce apoptosis of chondrocytes <xref ref-type="bibr" rid="ref18">Lotz et al., 1999</xref>.As a result, chondrocytes disappear and fibrochondrocytes develop in drug-treated cartilage.</p>
      <p>Collagen is distributed in almost all connective tissue. Type I collagen is the major protein in bone and occupies approximately 80% of the total proteins present in bone <xref ref-type="bibr" rid="ref41">Wu and Eyre, 1995</xref>. Collagen has mechanical functions and plays a substantial role in its toughness. Bone collagen abnormalities can lead to bone erosion <xref ref-type="bibr" rid="ref39">Viguet-Carrin et al., 2006</xref>. LPS and MPS have been reported to inhibit collagen and non-collagen protein synthesis in bone matrix <xref ref-type="bibr" rid="ref16">Larjava et al., 1987</xref><xref ref-type="bibr" rid="ref23">Millar et al., 1986</xref>. Moreover, researchers have shown that MPS inhibits synthesis of Wnt; since Wnt-mediated signals are involved in bone formation and resorption <xref ref-type="bibr" rid="ref15">Kobayashi et al., 2008</xref>, the inhibition of Wnt can lead to decreased bone formation [24]. Bone erosion may be also caused by negative regulation of Fas expression, which extends the life span of osteoclasts <xref ref-type="bibr" rid="ref42">Wu et al., 2003</xref>.</p>
      <p>LPS and MPS impact the immune system as well as proliferation of bone cells. The bone marrow cell populations include many different types, such as stem cells, adipocytes, progenitor endothelial cells and immune cells. LPS and MPS can cause apoptosis in bone marrow-derived cells, particularly immune cells. LPS induces macrophage apoptosis through two mechanisms: secretion of TNF-&#945; (early apoptosis) and production of nitric oxide (late apoptosis) <xref ref-type="bibr" rid="ref1">Azuma et al., 2000</xref>. Through the Fas signaling pathway, MPS promotes apoptosis of bone cells <xref ref-type="bibr" rid="ref45">Zalavras et al., 2003a</xref>. Glucocorticoids also rapidly induce apoptosis of T cells, B cells, neutrophils and eosinophils <xref ref-type="bibr" rid="ref21">McManus, 2003</xref><xref ref-type="bibr" rid="ref40">Walsh, 2000</xref>. In this study, apoptosis was clearly induced in these cells after MPS and LPS administration.</p>
      <p>Corticosteroids have been reported to stimulate osteoclast formation and lacunar resorption <xref ref-type="bibr" rid="ref7">Hirayama et al.,2002</xref>. LPS and MPS stimulate immune cells to produce many different types of cytokines which affect osteoclasts <xref ref-type="bibr" rid="ref35">Stamatos et al., 2010</xref>. There are three cytokine groups: (i) cytokines which activate osteoclasts <xref ref-type="bibr" rid="ref32">Shaarawy et al., 2003</xref>, (ii) cytokines which inhibit osteoclast activity <xref ref-type="bibr" rid="ref38">van't Hof and Ralston, 1997</xref>, and (iii) cytokines which have dual action on osteoclasts <xref ref-type="bibr" rid="ref47">Zupan et al., 2013</xref>. Some cytokines, such as IL1, TNF-&#945;, prostaglandin E2, G-CSF and RANK-L, induce the differentiation and activity of osteoclasts <xref ref-type="bibr" rid="ref1">Azuma et al.,2000</xref><xref ref-type="bibr" rid="ref31">Sato and Takayanagi, 2006</xref>. In contrast, cytokines like interleukin-4, gamma-interferon and transforming factor-beta inhibit both osteoclast formation and osteoclast activity <xref ref-type="bibr" rid="ref29">Roodman, 1993</xref>. LPS binds to osteoblasts in bone through CD14 receptor and stimulates them to produce cytokines and eicosanoids, thereby activating osteoclasts <xref ref-type="bibr" rid="ref10">Itoh et al., 2003</xref>. Osteoclasts are formed by the fusion of many cells derived from blood, such as mature monocytes and macrophages<xref ref-type="bibr" rid="ref37">Udagawa et al., 1990</xref>.</p>
      <p>In this study, LPS and MPS stimulated the division of bone marrow-derived mononuclear cells, beginning at week 3 after injection. This may supply the source for the formation of osteoclasts. In our study, expression of vascular-related factors demonstrated the importance of MPS and LPS on inducing necrosis of the femoral head. Cartilage is an important structural component of the body which does not have blood vessels and nerves <xref ref-type="bibr" rid="ref34">Sophia Fox et al., 2009</xref>. VEGFR-2 is expressed during articular cartilage growth and becomes quiescent at maturity. During osteoarthritis, the VEGFR-2 expression is also induced <xref ref-type="bibr" rid="ref17">Lingaraj et al., 2010</xref>. A study showed that VEGFR-2 was also expressed in osteoblasts, osteoclasts and chondrocytes during the endochondral bone formation <xref ref-type="bibr" rid="ref20">Maes and Carmeliet, 2008</xref>. During the process, hypertrophic chondrocytes die through induction of apoptosis and are replaced by osteoblasts <xref ref-type="bibr" rid="ref33">Shapiro et al., 2005</xref>. Another study has shown that VEGF and its receptor play an important role in the initial stages of femoral head necrosis. Moreover, expression of CD31 (PECAM), a marker on endothelial cells of the major organs and large vessels, were shown to be increased- a sign of invasion of vascular cells into cartilage <xref ref-type="bibr" rid="ref22">Melinte et al., 2012</xref><xref ref-type="bibr" rid="ref26">Pusztaszeri et al., 2006</xref>. In our study, the increased expression of vascular-related factors in the drug-treated mice group is an indication of invasion of blood vessel structures into the cartilage matrix, resulting in a changed cartilage structure.</p>
    </sec>
    <sec id="s5" sec-type="conclusion">
      <title>Conclusion</title>
      <p>This study shows that MPS, combined with LPS, can be used in mice to induce a model of early AVN of femoral head. We are aware that the mouse model does not show standardized pathogenesis of AVN of the femoral head. Nevertheless, our findings contribute to a better understanding about the process of AVN. This basic model should be suitable for investigating effective therapeutic modalities for AVN.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Y.</surname>
              <given-names>Azuma</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Kaji</given-names>
            </name>
            <name>
              <surname>R.</surname>
              <given-names>Katogi</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Takeshita</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Kudo</given-names>
            </name>
          </person-group>
          <article-title>Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts</article-title>
          <source>The Journal of biological chemistry</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>4858</fpage>
          <lpage>4864</lpage>
        </element-citation>
      </ref>
      <ref id="ref2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>B.</surname>
              <given-names>Beutler</given-names>
            </name>
            <name>
              <surname>E.T.</surname>
              <given-names>Rietschel</given-names>
            </name>
          </person-group>
          <article-title>Innate immune sensing and its roots: the story of endotoxin</article-title>
          <source>Nature Reviews Immunology</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>169</fpage>
          <lpage>176</lpage>
        </element-citation>
      </ref>
      <ref id="ref3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K.</surname>
              <given-names>Bobacz</given-names>
            </name>
            <name>
              <surname>I.G.</surname>
              <given-names>Sunk</given-names>
            </name>
            <name>
              <surname>J.G.</surname>
              <given-names>Hofstaetter</given-names>
            </name>
            <name>
              <surname>L.</surname>
              <given-names>Amoyo</given-names>
            </name>
            <name>
              <surname>C.D.</surname>
              <given-names>Toma</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Akira</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Weichhart</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Saemann</given-names>
            </name>
            <name>
              <surname>J.S.</surname>
              <given-names>Smolen</given-names>
            </name>
          </person-group>
          <article-title>Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7</article-title>
          <source>Arthritis and rheumatism</source>
          <year>2007</year>
          <volume>56</volume>
          <fpage>1880</fpage>
          <lpage>1893</lpage>
        </element-citation>
      </ref>
      <ref id="ref4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C.T.</surname>
              <given-names>Chen</given-names>
            </name>
            <name>
              <surname>N.</surname>
              <given-names>Burton-Wurster</given-names>
            </name>
            <name>
              <surname>C.</surname>
              <given-names>Borden</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Hueffer</given-names>
            </name>
            <name>
              <surname>S.E.</surname>
              <given-names>Bloom</given-names>
            </name>
            <name>
              <surname>G.</surname>
              <given-names>Lust</given-names>
            </name>
          </person-group>
          <article-title>Chondrocyte necrosis and apoptosis in impact damaged articular cartilage</article-title>
          <source>Journal of orthopaedic research: official publication of the Orthopaedic Research Society</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>703</fpage>
          <lpage>711</lpage>
        </element-citation>
      </ref>
      <ref id="ref5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>JD</surname>
              <given-names>Esko</given-names>
            </name>
            <name>
              <surname>K</surname>
              <given-names>Kimata</given-names>
            </name>
            <name>
              <surname>L.</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Proteoglycans and Sulfated Glycosaminoglycans. In: Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology</article-title>
          <source>Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, Chapter 16</source>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="ref6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Q.</surname>
              <given-names>Espinassous</given-names>
            </name>
            <name>
              <surname>E.</surname>
              <given-names>Garcia-de-Paco</given-names>
            </name>
            <name>
              <surname>I.</surname>
              <given-names>Garcia-Verdugo</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Synguelakis</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>von Aulock</given-names>
            </name>
            <name>
              <surname>J.M.</surname>
              <given-names>Sallenave</given-names>
            </name>
            <name>
              <surname>A.N.</surname>
              <given-names>McKenzie</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Kanellopoulos</given-names>
            </name>
          </person-group>
          <article-title>IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex</article-title>
          <source>J</source>
          <year>2009</year>
          <volume>Immunol183</volume>
          <fpage>1446</fpage>
          <lpage>1455</lpage>
        </element-citation>
      </ref>
      <ref id="ref7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>T.</surname>
              <given-names>Hirayama</given-names>
            </name>
            <name>
              <surname>L.</surname>
              <given-names>Danks</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Sabokbar</given-names>
            </name>
            <name>
              <surname>N.A.</surname>
              <given-names>Athanasou</given-names>
            </name>
          </person-group>
          <article-title>Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis</article-title>
          <source>Rheumatology (Oxford)</source>
          <year>2002</year>
          <volume>41</volume>
          <fpage>1232</fpage>
          <lpage>1239</lpage>
        </element-citation>
      </ref>
      <ref id="ref8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>T.</surname>
              <given-names>Ichiseki</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Matsumoto</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Nishino</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Kaneuji</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Katsuda</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and vascular permeability in steroid-induced osteonecrosis model</article-title>
          <source>J Orthop Sci</source>
          <year>2004a</year>
          <volume>9</volume>
          <fpage>509</fpage>
          <lpage>515</lpage>
        </element-citation>
      </ref>
      <ref id="ref9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>T.</surname>
              <given-names>Ichiseki</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Matsumoto</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Nishino</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Kaneuji</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Katsuda</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and vascular permeability in steroid-induced osteonecrosis model</article-title>
          <source>Journal of Orthopaedic Science</source>
          <year>2004b</year>
          <volume>9</volume>
          <fpage>509</fpage>
          <lpage>515</lpage>
        </element-citation>
      </ref>
      <ref id="ref10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K.</surname>
              <given-names>Itoh</given-names>
            </name>
            <name>
              <surname>N.</surname>
              <given-names>Udagawa</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Kobayashi</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Suda</given-names>
            </name>
            <name>
              <surname>X.</surname>
              <given-names>Li</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Takami</given-names>
            </name>
            <name>
              <surname>N.</surname>
              <given-names>Okahashi</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Nishihara</given-names>
            </name>
            <name>
              <surname>N.</surname>
              <given-names>Takahashi</given-names>
            </name>
          </person-group>
          <article-title>Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages</article-title>
          <source>J</source>
          <year>2003</year>
          <volume>Immunol170</volume>
          <fpage>3688</fpage>
          <lpage>3695</lpage>
        </element-citation>
      </ref>
      <ref id="ref11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.B.</surname>
              <given-names>J. Anthony Parker</given-names>
            </name>
            <name name-style="given-only">
              <given-names>S. S. Tumeh</given-names>
            </name>
          </person-group>
          <article-title>AVASCULAR NECROSIS (Harvard Univeristy)</article-title>
          <year>1988</year>
        </element-citation>
      </ref>
      <ref id="ref12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M.A.</surname>
              <given-names>Kerachian</given-names>
            </name>
            <name>
              <surname>D.</surname>
              <given-names>Cournoyer</given-names>
            </name>
            <name>
              <surname>E.J.</surname>
              <given-names>Harvey</given-names>
            </name>
            <name>
              <surname>T.Y.</surname>
              <given-names>Chow</given-names>
            </name>
            <name>
              <surname>L.R.</surname>
              <given-names>Begin</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Nahal</given-names>
            </name>
            <name>
              <surname>C.</surname>
              <given-names>Seguin</given-names>
            </name>
          </person-group>
          <article-title>New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model</article-title>
          <source>Arthritis Res Ther</source>
          <year>2010a</year>
          <volume>12</volume>
          <fpage>R124</fpage>
        </element-citation>
      </ref>
      <ref id="ref13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M.A.</surname>
              <given-names>Kerachian</given-names>
            </name>
            <name>
              <surname>D.</surname>
              <given-names>Cournoyer</given-names>
            </name>
            <name>
              <surname>E.J.</surname>
              <given-names>Harvey</given-names>
            </name>
            <name>
              <surname>T.Y.</surname>
              <given-names>Chow</given-names>
            </name>
            <name>
              <surname>L.R.</surname>
              <given-names>B&#233;gin</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Nahal</given-names>
            </name>
            <name>
              <surname>C.</surname>
              <given-names>S&#233;guin</given-names>
            </name>
          </person-group>
          <article-title>Research article New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: micro-array analysis of gene expression in a rat model</article-title>
          <year>2010b</year>
        </element-citation>
      </ref>
      <ref id="ref14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>H.K.</surname>
              <given-names>Kim</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Bian</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Aya-ay</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Garces</given-names>
            </name>
            <name>
              <surname>E.F.</surname>
              <given-names>Morgan</given-names>
            </name>
            <name>
              <surname>S.R.</surname>
              <given-names>Gilbert</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia and HIF-1&#945; expression in the epiphyseal cartilage following ischemic injury to the immature femoral head</article-title>
          <source>Bone</source>
          <year>2009</year>
          <volume>45</volume>
          <fpage>280</fpage>
          <lpage>288</lpage>
        </element-citation>
      </ref>
      <ref id="ref15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Y.</surname>
              <given-names>Kobayashi</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Maeda</given-names>
            </name>
            <name>
              <surname>N.</surname>
              <given-names>Takahashi</given-names>
            </name>
          </person-group>
          <article-title>Roles of Wnt signaling in bone formation and resorption</article-title>
          <source>Japanese Dental Science Review</source>
          <year>2008</year>
          <volume>44</volume>
          <fpage>76</fpage>
          <lpage>82</lpage>
        </element-citation>
      </ref>
      <ref id="ref16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>H.</surname>
              <given-names>Larjava</given-names>
            </name>
            <name>
              <surname>V.J.</surname>
              <given-names>Uitto</given-names>
            </name>
            <name>
              <surname>E.</surname>
              <given-names>Eerola</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Haapasalo</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of gingival fibroblast growth by Bacteroides gingivalis</article-title>
          <source>Infect Immun</source>
          <year>1987</year>
          <volume>55</volume>
          <fpage>201</fpage>
          <lpage>205</lpage>
        </element-citation>
      </ref>
      <ref id="ref17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K.</surname>
              <given-names>Lingaraj</given-names>
            </name>
            <name>
              <surname>C.K.</surname>
              <given-names>Poh</given-names>
            </name>
            <name>
              <surname>W.</surname>
              <given-names>Wang</given-names>
            </name>
          </person-group>
          <article-title>Vascular endothelial growth factor (VEGF) is expressed during articular cartilage growth and re-expressed in osteoarthritis</article-title>
          <source>Annals of the Academy of</source>
          <year>2010</year>
          <volume>Medicine</volume>
          <fpage>Singapore 39, 399</fpage>
          <lpage>403</lpage>
        </element-citation>
      </ref>
      <ref id="ref18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M.</surname>
              <given-names>Lotz</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Hashimoto</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Kuhn</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of chondrocyte apoptosis</article-title>
          <source>Osteoarthritis and cartilage /</source>
          <year>1999</year>
          <volume>OARS</volume>
          <fpage>Osteoarthritis Research Society 7, 389</fpage>
          <lpage>391</lpage>
        </element-citation>
      </ref>
      <ref id="ref19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>B.T.</surname>
              <given-names>MacDonald</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Tamai</given-names>
            </name>
            <name>
              <surname>X.</surname>
              <given-names>He</given-names>
            </name>
          </person-group>
          <article-title>Wnt/&#946;-catenin signaling: components, mechanisms, and diseases</article-title>
          <source>Developmental cell</source>
          <year>2009</year>
          <volume>17</volume>
          <fpage>9</fpage>
          <lpage>26</lpage>
        </element-citation>
      </ref>
      <ref id="ref20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C.</surname>
              <given-names>Maes</given-names>
            </name>
            <name>
              <surname>G.</surname>
              <given-names>Carmeliet</given-names>
            </name>
          </person-group>
          <article-title>Vascular and Nonvascular Roles of VEGF in Bone Development.</article-title>
          <source>In VEGF in Development (Springer New York)</source>
          <year>2008</year>
          <fpage>79</fpage>
          <lpage>90</lpage>
        </element-citation>
      </ref>
      <ref id="ref21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>R.</surname>
              <given-names>McManus</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of steroid action and resistance in inflammation and disease</article-title>
          <source>The Journal of endocrinology</source>
          <year>2003</year>
          <volume>178</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
        </element-citation>
      </ref>
      <ref id="ref22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>R.</surname>
              <given-names>Melinte</given-names>
            </name>
            <name>
              <surname>I.</surname>
              <given-names>Jung</given-names>
            </name>
            <name>
              <surname>L.</surname>
              <given-names>Georgescu</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Gurzu</given-names>
            </name>
          </person-group>
          <article-title>VEGF and CD31 expression in arthritic synovium and cartilage of human knee joints</article-title>
          <source>Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie</source>
          <year>2012</year>
          <volume>53</volume>
          <fpage>911</fpage>
          <lpage>915</lpage>
        </element-citation>
      </ref>
      <ref id="ref23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S.J.</surname>
              <given-names>Millar</given-names>
            </name>
            <name>
              <surname>E.G.</surname>
              <given-names>Goldstein</given-names>
            </name>
            <name>
              <surname>M.J.</surname>
              <given-names>Levine</given-names>
            </name>
            <name>
              <surname>E.</surname>
              <given-names>Hausmann</given-names>
            </name>
          </person-group>
          <article-title>Modulation of bone metabolism by two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis</article-title>
          <source>Infect Immun</source>
          <year>1986</year>
          <volume>51</volume>
          <fpage>302</fpage>
          <lpage>306</lpage>
        </element-citation>
      </ref>
      <ref id="ref24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K.</surname>
              <given-names>Miyanishi</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Yamamoto</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Irisa</given-names>
            </name>
            <name>
              <surname>G.</surname>
              <given-names>Motomura</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Jingushi</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Sueishi</given-names>
            </name>
            <name>
              <surname>Y.</surname>
              <given-names>Iwamoto</given-names>
            </name>
          </person-group>
          <article-title>Effects of different corticosteroids on the development of osteonecrosis in rabbits</article-title>
          <source>Rheumatology</source>
          <year>2005</year>
          <volume>44</volume>
          <fpage>332</fpage>
          <lpage>336</lpage>
        </element-citation>
      </ref>
      <ref id="ref25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>F.</surname>
              <given-names>Nakazawa</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Matsuno</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Yudoh</given-names>
            </name>
            <name>
              <surname>Y.</surname>
              <given-names>Watanabe</given-names>
            </name>
            <name>
              <surname>R.</surname>
              <given-names>Katayama</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Kimura</given-names>
            </name>
          </person-group>
          <article-title>Corticosteroid treatment induces chondrocyte apoptosis in an experimental arthritis model and in chondrocyte cultures</article-title>
          <source>Clinical and experimental rheumatology</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>773</fpage>
          <lpage>781</lpage>
        </element-citation>
      </ref>
      <ref id="ref26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M.P.</surname>
              <given-names>Pusztaszeri</given-names>
            </name>
            <name>
              <surname>W.</surname>
              <given-names>Seelentag</given-names>
            </name>
            <name>
              <surname>F.T.</surname>
              <given-names>Bosman</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical expression of endothelial markers CD31, CD34, von Wille-brand factor, and Fli-1 in normal human tissues</article-title>
          <source>The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society</source>
          <year>2006</year>
          <volume>54</volume>
          <fpage>385</fpage>
          <lpage>395</lpage>
        </element-citation>
      </ref>
      <ref id="ref27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>W.</surname>
              <given-names>Qian</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Li</given-names>
            </name>
            <name>
              <surname>C.</surname>
              <given-names>Yan-Ping</given-names>
            </name>
            <name>
              <surname>Y.</surname>
              <given-names>Lin</given-names>
            </name>
            <name>
              <surname>L.</surname>
              <given-names>Wei</given-names>
            </name>
            <name>
              <surname>W.</surname>
              <given-names>Xiao-Ning</given-names>
            </name>
          </person-group>
          <article-title>A rabbit model of hormone-induced early avascular necrosis of the femoral head</article-title>
          <source>Biomedical and Environmental Sciences</source>
          <year>2008</year>
          <volume>21</volume>
          <fpage>398</fpage>
          <lpage>403</lpage>
        </element-citation>
      </ref>
      <ref id="ref28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>L.</surname>
              <given-names>Qin</given-names>
            </name>
            <name>
              <surname>G.</surname>
              <given-names>Zhang</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Sheng</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Yeung</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Yeung</given-names>
            </name>
            <name>
              <surname>C.</surname>
              <given-names>Chan</given-names>
            </name>
            <name>
              <surname>W.</surname>
              <given-names>Cheung</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Griffith</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Chiu</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Leung</given-names>
            </name>
          </person-group>
          <article-title>Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone</article-title>
          <source>Bone</source>
          <year>2006</year>
          <volume>39</volume>
          <fpage>863</fpage>
          <lpage>871</lpage>
        </element-citation>
      </ref>
      <ref id="ref29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G.D.</surname>
              <given-names>Roodman</given-names>
            </name>
          </person-group>
          <article-title>Role of cytokines in the regulation of bone resorption</article-title>
          <source>Calcified tissue international 53 Suppl</source>
          <year>1993</year>
          <volume>1</volume>
          <fpage>S94</fpage>
          <lpage>98</lpage>
        </element-citation>
      </ref>
      <ref id="ref30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S.Y.</surname>
              <given-names>Ryoo</given-names>
            </name>
            <name>
              <surname>S.H.</surname>
              <given-names>Jo</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Kwak</given-names>
            </name>
            <name>
              <surname>J.H.</surname>
              <given-names>Lee</given-names>
            </name>
            <name>
              <surname>H.J.</surname>
              <given-names>Jhun</given-names>
            </name>
            <name>
              <surname>A.S.</surname>
              <given-names>Sobti</given-names>
            </name>
            <name>
              <surname>K.J.</surname>
              <given-names>Oh</given-names>
            </name>
          </person-group>
          <article-title>Effect of lipopolysaccharide (LPS) on mouse model of steroid-induced avascular necrosis in the femoral head (ANFH)</article-title>
          <source>Journal of microbiology and biotechnology</source>
          <year>2014</year>
          <volume>24</volume>
          <fpage>394</fpage>
          <lpage>400</lpage>
        </element-citation>
      </ref>
      <ref id="ref31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K.</surname>
              <given-names>Sato</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Takayanagi</given-names>
            </name>
          </person-group>
          <article-title>Osteoclasts, rheumatoid arthritis, and osteoimmunology</article-title>
          <source>Current opinion in rheumatology</source>
          <year>2006</year>
          <volume>18</volume>
          <fpage>419</fpage>
          <lpage>426</lpage>
        </element-citation>
      </ref>
      <ref id="ref32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M.</surname>
              <given-names>Shaarawy</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Zaki</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Sheiba</given-names>
            </name>
            <name>
              <surname>A.M.</surname>
              <given-names>El-Minawi</given-names>
            </name>
          </person-group>
          <article-title>Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis</article-title>
          <source>Clinical laboratory</source>
          <year>2003</year>
          <volume>49</volume>
          <fpage>625</fpage>
          <lpage>636</lpage>
        </element-citation>
      </ref>
      <ref id="ref33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>I.M.</surname>
              <given-names>Shapiro</given-names>
            </name>
            <name>
              <surname>C.S.</surname>
              <given-names>Adams</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Freeman</given-names>
            </name>
            <name>
              <surname>V.</surname>
              <given-names>Srinivas</given-names>
            </name>
          </person-group>
          <article-title>Fate of the hypertrophic chondrocyte: microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate</article-title>
          <source>Birth defects research Part</source>
          <year>2005</year>
          <volume>C</volume>
          <fpage>Embryo today: reviews 75, 330</fpage>
          <lpage>339</lpage>
        </element-citation>
      </ref>
      <ref id="ref34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.J.</surname>
              <given-names>Sophia Fox</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Bedi</given-names>
            </name>
            <name>
              <surname>S.A.</surname>
              <given-names>Rodeo</given-names>
            </name>
          </person-group>
          <article-title>The Basic Science of Articular Cartilage: Structure, Composition, and Function</article-title>
          <source>Sports Health</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>461</fpage>
          <lpage>468</lpage>
        </element-citation>
      </ref>
      <ref id="ref35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>N.M.</surname>
              <given-names>Stamatos</given-names>
            </name>
            <name>
              <surname>I.</surname>
              <given-names>Carubelli</given-names>
            </name>
            <name>
              <surname>D.</surname>
              <given-names>van de Vlekkert</given-names>
            </name>
            <name>
              <surname>E.J.</surname>
              <given-names>Bonten</given-names>
            </name>
            <name>
              <surname>N.</surname>
              <given-names>Papini</given-names>
            </name>
            <name>
              <surname>C.</surname>
              <given-names>Feng</given-names>
            </name>
            <name>
              <surname>B.</surname>
              <given-names>Venerando</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>d'Azzo</given-names>
            </name>
            <name>
              <surname>A.S.</surname>
              <given-names>Cross</given-names>
            </name>
            <name>
              <surname>L.X.</surname>
              <given-names>Wang</given-names>
            </name>
          </person-group>
          <article-title>LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity</article-title>
          <source>Journal of leukocyte biology</source>
          <year>2010</year>
          <volume>88</volume>
          <fpage>1227</fpage>
          <lpage>1239</lpage>
        </element-citation>
      </ref>
      <ref id="ref36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>R.</surname>
              <given-names>Todhunter</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Fubini</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Wootton</given-names>
            </name>
            <name>
              <surname>G.</surname>
              <given-names>Lust</given-names>
            </name>
          </person-group>
          <article-title>Effect of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants</article-title>
          <source>The Journal of rheumatology</source>
          <year>1996</year>
          <volume>23</volume>
          <fpage>1207</fpage>
          <lpage>1213</lpage>
        </element-citation>
      </ref>
      <ref id="ref37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>N.</surname>
              <given-names>Udagawa</given-names>
            </name>
            <name>
              <surname>N.</surname>
              <given-names>Takahashi</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Akatsu</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Tanaka</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Sasaki</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Nishihara</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Koga</given-names>
            </name>
            <name>
              <surname>T.J.</surname>
              <given-names>Martin</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Suda</given-names>
            </name>
          </person-group>
          <article-title>Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells</article-title>
          <source>Proceedings of the National Academy of Sciences of the United States of America</source>
          <year>1990</year>
          <volume>87</volume>
          <fpage>7260</fpage>
          <lpage>7264</lpage>
        </element-citation>
      </ref>
      <ref id="ref38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>R.J.</surname>
              <given-names>Hof</given-names>
            </name>
            <name>
              <surname>S.H.</surname>
              <given-names>Ralston</given-names>
            </name>
          </person-group>
          <article-title>Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity</article-title>
          <source>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</source>
          <year>1997</year>
          <volume>12</volume>
          <fpage>1797</fpage>
          <lpage>1804</lpage>
        </element-citation>
      </ref>
      <ref id="ref39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S.</surname>
              <given-names>Viguet-Carrin</given-names>
            </name>
            <name>
              <surname>P.</surname>
              <given-names>Garnero</given-names>
            </name>
            <name>
              <surname>P.D.</surname>
              <given-names>Delmas</given-names>
            </name>
          </person-group>
          <article-title>The role of collagen in bone strength</article-title>
          <source>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>319</fpage>
          <lpage>336</lpage>
        </element-citation>
      </ref>
      <ref id="ref40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G.M.</surname>
              <given-names>Walsh</given-names>
            </name>
          </person-group>
          <article-title>Eosinophil apoptosis: mechanisms and clinical relevance in asthmatic and allergic inflammation</article-title>
          <source>British journal of haematology</source>
          <year>2000</year>
          <volume>111</volume>
          <fpage>61</fpage>
          <lpage>67</lpage>
        </element-citation>
      </ref>
      <ref id="ref41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>J.J.</surname>
              <given-names>Wu</given-names>
            </name>
            <name>
              <surname>D.R.</surname>
              <given-names>Eyre</given-names>
            </name>
          </person-group>
          <article-title>Structural analysis of cross-linking domains in cartilage type XI collagen. Insights on polymeric assembly</article-title>
          <source>The Journal of biological chemistry</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>18865</fpage>
          <lpage>18870</lpage>
        </element-citation>
      </ref>
      <ref id="ref42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>X.</surname>
              <given-names>Wu</given-names>
            </name>
            <name>
              <surname>M.A.</surname>
              <given-names>McKenna</given-names>
            </name>
            <name>
              <surname>X.</surname>
              <given-names>Feng</given-names>
            </name>
            <name>
              <surname>T.R.</surname>
              <given-names>Nagy</given-names>
            </name>
            <name>
              <surname>J.M.</surname>
              <given-names>McDonald</given-names>
            </name>
          </person-group>
          <article-title>Osteoclast apoptosis: the role of Fas in vivo and in vitro</article-title>
          <source>Endocrinology</source>
          <year>2003</year>
          <volume>144</volume>
          <fpage>5545</fpage>
          <lpage>5555</lpage>
        </element-citation>
      </ref>
      <ref id="ref43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>X.</surname>
              <given-names>Wu</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Yang</given-names>
            </name>
            <name>
              <surname>D.</surname>
              <given-names>Duan</given-names>
            </name>
            <name>
              <surname>Y.</surname>
              <given-names>Zhang</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Wang</given-names>
            </name>
          </person-group>
          <article-title>Experimental osteonecrosis induced by a combination of low-dose lipopolysaccharide and high-dose methylprednisolone in rabbits</article-title>
          <source>Joint Bone Spine</source>
          <year>2008</year>
          <volume>75</volume>
          <fpage>573</fpage>
          <lpage>578</lpage>
        </element-citation>
      </ref>
      <ref id="ref44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>L.</surname>
              <given-names>Yin</given-names>
            </name>
            <name>
              <surname>Y.-b.</surname>
              <given-names>Li</given-names>
            </name>
            <name>
              <surname>Y.-s.</surname>
              <given-names>Wang</given-names>
            </name>
          </person-group>
          <article-title>Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis</article-title>
          <source>CHINESE MEDICAL JOURNAL-BEIJING-ENGLISH</source>
          <year>2006</year>
          <volume>EDITION-119</volume>
          <fpage>581</fpage>
        </element-citation>
      </ref>
      <ref id="ref45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C.</surname>
              <given-names>Zalavras</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Shah</given-names>
            </name>
            <name>
              <surname>M.J.</surname>
              <given-names>Birnbaum</given-names>
            </name>
            <name>
              <surname>B.</surname>
              <given-names>Frenkel</given-names>
            </name>
          </person-group>
          <article-title>Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis</article-title>
          <source>Crit Rev Eukaryot Gene Expr</source>
          <year>2003a</year>
          <volume>13</volume>
          <fpage>221</fpage>
          <lpage>235</lpage>
        </element-citation>
      </ref>
      <ref id="ref46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C.</surname>
              <given-names>Zalavras</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Shah</given-names>
            </name>
            <name>
              <surname>M.J.</surname>
              <given-names>Birnbaum</given-names>
            </name>
            <name>
              <surname>B.</surname>
              <given-names>Frenkel</given-names>
            </name>
          </person-group>
          <article-title>Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis</article-title>
          <source>Critical Reviews&#8482; in Eukaryotic Gene Expression</source>
          <year>2003b</year>
          <volume>13</volume>
        </element-citation>
      </ref>
      <ref id="ref47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>J.</surname>
              <given-names>Zupan</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Jeras</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Marc</given-names>
            </name>
          </person-group>
          <article-title>Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts</article-title>
          <source>Biochem Med (Zagreb)</source>
          <year>2013</year>
          <volume>23</volume>
          <fpage>43</fpage>
          <lpage>63</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>